Camelot Portfolios’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Camelot Portfolios’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-383	Closed	-$46K	–	179
2016 Q1	$46K	Hold	383	–	–	0.03%	156
2015 Q4	$46K	Hold	383	–	–	0.03%	148
2015 Q3	$65K	Hold	383	–	–	0.04%	146
2015 Q2	$74K	Hold	383	–	–	0.04%	166
2015 Q1	$57K	Hold	383	–	–	0.03%	165
2014 Q4	$60K	Hold	383	–	–	0.03%	165
2014 Q3	$55K	Hold	383	–	–	0.03%	156
2014 Q2	$50K	Buy	+383	New	+$48.6K	0.03%	156

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

GCP

Glen Capital Partners Waltham, Massachusetts $68.9M AUM 21.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Camelot Portfolios's SRGA Position: Q2 2016 in Review

Camelot Portfolios sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2016, closing a stake of 383 shares — an estimated $46K sold.

Camelot Portfolios first reported a position in SRGA in Q2 2014 and held it in 8 quarters. The position peaked at $74K in Q2 2015. 111 funds tracked by Wall St. Rank hold SRGA as of Q2 2016.

Camelot Portfolios reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Camelot Portfolios sold 383 Surgalign Holdings, Inc. Common Stock shares in Q2 2016, an estimated $46K.
Camelot Portfolios first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Camelot Portfolios's Surgalign Holdings, Inc. Common Stock position peaked at $74K in Q2 2015.
111 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2016.

Based on Camelot Portfolios's 13F filing for Q2 2016, filed 12 Aug 2016.